Hyperphosphatemia is a condition that elevates phosphate levels in the blood. This condition can be caused due to the shift of phosphate from intracellular to extracellular space, excessive phosphate intake, and decrease in excretion of phosphate. High levels of phosphate in the blood can be avoided by dietary restrictions and with the use of phosphate binders. Hyperphosphatemia is a primary cause of morbidity and mortality in patients with chronic kidney disease. Since long back the hyperphosphatemia and increased risk of death from cardiovascular disease/vascular calcification are strongly associated with each other. This, in turn, increases the risk of cardiovascular disease among the patients suffering from hyperphosphatemia.

Major factors driving the market include rise in prevalence of chronic diseases, high unmet medical needs, increase in the number of people undergoing dialysis, large geriatric population, and surge in public awareness worldwide. Diabetes and hypertension are the main causes of renal failure, which leads to hyperphosphatemia. However, stringent regulations by regulatory bodies such as the Food and Drug Administration (FDA), non-adherence to treatment regimens, and rise in side effects of hyperphosphatemia drugs are likely to inhibit the market. According to FDA use of hyperphosphatemia drugs for the treatment of high or low phosphorus levels in the human body is neither safe nor effective. High growth potential in untapped economies, such as India, China, South Africa, and Brazil, is expected to create lucrative opportunities for key players. Rise in geriatric population and increase in cases of osteoporosis in Asia Pacific is anticipated to drive the market. Osteoporosis is often undertreated and underdiagnosed, which is driving the hyperphosphatemia drugs market in Asia Pacific. The available calcium, lanthanum, sevelamer, and iron-based drugs for treating hyperphosphatemia are associated with certain side effects. The long-term use of calcium-based drugs such as calcium carbonate and calcium acetate can cause vascular calcification.

The global hyperphosphatemia drugs market has been segmented based on product, dosage form, distribution channel, and region. In terms of product, the market has been divided into aluminum-based, calcium-based, magnesium-based, iron-based phosphate binders, and other phosphate binders. The calcium-based phosphate binder’s formulation is expected to dominate the hyperphosphatemia drugs market. Calcium-based phosphorus binders have substituted aluminum-based phosphorus binders and can serve as calcium supplements. The calcium-based phosphate binders segment held the largest share of the market in 2017. The iron-based phosphate binders segment is anticipated to expand at a considerable CAGR during the forecast period. The aluminium-based phosphate binders and magnesium-based phosphorus binders are extensively used and are employed to treat hyperphosphatemia in dialysis patients. Based on dosage form, the hyperphosphatemia drugs market has been classified into syrups, tablets, and capsules. In terms of distribution channel, the market has been categorized into specialty pharmacies, hospital pharmacies, home care providers, and others.

Based on geography, the global hyperphosphatemia drugs market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the hyperphosphatemia drugs market in 2017, due to factors such as increase in aging population, rise in number of osteoporosis cases, and changing dietary habits. Increase in prevalence of osteoporosis is a driving the hyperphosphatemia drugs market in North America. The hyperphosphatemia drugs market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. The hyperphosphatemia drugs market in India and China is anticipated to expand at the highest CAGR during the forecast period. Increase in geriatric population in China and India is projected to drive the hyperphosphatemia drugs market in Asia Pacific. There is an estimation that India’s geriatric population will augment significantly throughout the decades.

Key players operating in the global hyperphosphatemia drugs market include Amag Pharmaceuticals, Johnson And Johnson, Cipla, DSM Sinochem Pharmaceuticals, Keryx Biopharmaceuticals, Pharmacal, Sun Pharm Inc., Zeria Pharmaceutical, Ultragenyx, Bruno Pharmaceutical Spa, Fermenta Biotech Ltd, Pfizer Inc., Roche Diagnostics Corporation, R.H. Moore Drug Co., Vifor Pharma, Sanofi, Shire, and Fresenius Medical Care.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Hyperphosphatemia Drugs Market

Pre Book